Page last updated: 2024-10-30

lansoprazole and Aspergillosis

lansoprazole has been researched along with Aspergillosis in 1 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Aspergillosis: Infections with fungi of the genus ASPERGILLUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsubokura, M1
Miura, Y1
Itokawa, T1
Murata, K1
Takei, N1
Higaki, T1
Murashige, N1
Kami, M1
Komatsu, T1

Other Studies

1 other study available for lansoprazole and Aspergillosis

ArticleYear
Fatal dysrhythmia following initiation of lansoprazole during a long-term course of voriconazole.
    Journal of clinical pharmacology, 2011, Volume: 51, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Antifungal Agents; Aspergillosis;

2011